Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 14/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20709770 | 0.90 | PPARD (0.37) | PPARDMAOBSMN1; SMN2LMNACYP3A4 | |
| SCHEMBL10075731 | 0.89 | GAA (0.35) | GAASMN1; SMN2LMNACYP3A4 | |
| SCHEMBL20709768 | 0.89 | MAOB (0.35) | PPARDMAOBGAA | |
| SCHEMBL10075763 | 0.87 | THRA (0.34) | GAASMN1; SMN2LMNACYP3A4 | |
| SCHEMBL10075766 | 0.87 | KDM4E (0.36) | GAASMN1; SMN2LMNACYP3A4 | |
| SCHEMBL10075781 | 0.86 | SMN1; SMN2 (0.32) | GAASMN1; SMN2LMNACYP3A4 | |
| SCHEMBL19751028 | 0.86 | PPARD (0.35) | PPARDMAOBGAASMN1; SMN2LMNA | |
| SCHEMBL10075786 | 0.85 | SLC6A2 (0.31) | GAASMN1; SMN2POLB | |
| SCHEMBL10075773 | 0.85 | MAPT (0.32) | GAASMN1; SMN2LMNA | |
| SCHEMBL22639048 | 0.84 | GAA (0.43) | GAASMN1; SMN2LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586827-B1 | CURABLE RESIN COMPOSITION | ADEKA CORP (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-8735511-B2 | Curing resin composition | ADEKA CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| US-8735511-B2 | Curing resin composition | ADEKA CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| US-20120115972-A1 | CURING RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20120115972-A1 | CURING RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2012-05-10 | — | — | US | disclosed |
| US-8148045-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-8148045-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| EP-2327689-B1 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORP (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2327689-A1 | Oxime ester compound and photopolymerization initiator containing the same | Adeka Corporation (JP) | 2011-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | OXER1, OR10J3, CDK11B | PPARD 2616/4885MAOB 1080/4885GAA 4794/4885 |
| US-20120115972-A1 | CURING RESIN COMPOSITION | LTA, LOXL1, PLOD2 | PPARD 766/4885MAOB 666/4885GAA 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.